Eligard 22.5 mg (Leuprolide Acetate POWDER FOR SUSPENSION, SUSTAINED-RELEASE) 22.5 MG

Eligard 22.5 mg is a sustained-release powder for suspension used for hormone-related conditions. This subcutaneous injection contains leuprolide acetate, a synthetic hormone therapy.

Strength

22.5 MG

Pack Size

0.37ML

Manufacturer / TM Owner

TOLMAR INTERNATIONAL LTD.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Eligard 22.5 mg is primarily used for hormone therapy in conditions like prostate cancer. It works by reducing the production of certain hormones. People often ask, 'What is Eligard used for?' It is typically prescribed for managing symptoms related to hormone-sensitive conditions.

Side Effects

Common effects of Eligard 22.5 mg may include temporary discomfort at the injection site, hot flashes, and fatigue. Some users report changes in mood or energy levels. These effects vary and are not experienced by everyone.

Precautions & Warnings

Eligard 22.5 mg should be handled with care, as it is a sustained-release medication. It is important to follow the administration guidelines provided by a healthcare professional. Store it properly to maintain its effectiveness.

Avoid Interactions

Eligard 22.5 mg may interact with other medications, including those that affect hormone levels. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions.

Frequently Asked Questions

Eligard 22.5 mg is used for hormone therapy in conditions like prostate cancer. It helps manage symptoms by reducing hormone production.

Eligard 22.5 mg is administered as a subcutaneous injection. It is important to follow the administration guidelines provided by a healthcare professional.

Common effects may include temporary discomfort at the injection site, hot flashes, and fatigue. These effects vary and are not experienced by everyone.

Eligard 22.5 mg may interact with other medications, especially those that affect hormone levels. It is advisable to discuss all current medications with a healthcare provider.

Eligard 22.5 mg should be stored as per the instructions provided. Proper storage is crucial to maintain its effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.